HCA Healthcare (HCA)
(Delayed Data from NYSE)
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Zacks News
Centene's Health Net Wins Medi-Cal Contract in California
by Zacks Equity Research
CNC's Health Net unit secures a 54-month Medi-Cal dental contract, which, in turn, is likely to boost its Medicaid membership and presence across California.
5 Dividend Growth Stocks Likely to Outperform Amid Low Rates
by Sweta Killa
NetApp, Cabot, Leidos Holdings, Charles River and HCA Healthcare could be compelling picks amid a low rate scenario.
Stocks Make Record Highs: 3 Top Buys for the Next Bull Run
by Ethan Feller
HCA Healthcare, Fortinet and PayPal stocks all offer compelling bullish opportunities
HCA (HCA) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
HCA (HCA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
How HCA Healthcare (HCA) Stock Stands Out in a Strong Industry
by Zacks Equity Research
HCA Healthcare (HCA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
HCA Healthcare (HCA) Boasts Earnings & Price Momentum: Should You Buy?
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
New Strong Buy Stocks for September 20th
by Zacks Equity Research
QFIN, CLCO, HCA, STRL and CSGS have been added to the Zacks Rank #1 (Strong Buy) List on September 20, 2024.
Universal Health Up 23% in 3 Months: Time to Buy or Miss the Boat?
by Debasmita Chatterjee
UHS witnesses revenue growth from increased patient volumes and strategic initiatives. An extensive treatment network remains an added strength.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Zacks.com featured highlights include HCA Healthcare, Hubbell, Ferrari and Vertex
by Zacks Equity Research
HCA Healthcare, Hubbell, Ferrari and Vertex have been highlighted in this Screen of The Week article.
HCA Healthcare Stock Up 18.4% in 3 Months: Can You Afford to Miss Out?
by Zubia Masood
HCA benefits from expanding insurance coverage, rising demand and improving margins.
4 GARP Stocks to Scoop up for Maximum Returns
by Zacks Equity Research
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. HCA, HUBB, RACE and VERX are some stocks that hold promise.
HCA Healthcare (HCA) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
New Strong Buy Stocks for September 12th
by Zacks Equity Research
AFRM, SBSI, LYTS, CM and HCA have been added to the Zacks Rank #1 (Strong Buy) List on September 12, 2024.
Cigna Stock Gains 26% in a Year: What Lies Ahead for Investors?
by Zacks Equity Research
CI benefits from improved premiums resulting from an extensive customer base. Buyouts and adequate operating cash flows are other tailwinds.
2 Sector ETFs & Stocks to Bet on Following August Jobs Data
by Sanghamitra Saha
The U.S. economy added 142, 000 jobs in August 2024, more than a downwardly revised 89, 000 in July but below forecasts of 160, 000.
Are Medical Stocks Lagging HCA Healthcare (HCA) This Year?
by Zacks Equity Research
Here is how HCA Healthcare (HCA) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Zacks.com featured highlights include Vertiv, Charles River Associates, Cabot, Leidos and HCA Healthcare
by Zacks Equity Research
Vertiv, Charles River Associates, Cabot, Leidos and HCA Healthcare are part of the Zacks Screen of the Week article.
Top Stock Reports for Apple, Tesla & NextEra Energy
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Tesla, Inc. (TSLA) and NextEra Energy, Inc. (NEE), as well as two micro-cap stocks Investors Title Company (ITIC) and Autoscope Technologies Corporation (AATC).
Select Medical Agrees to Acquire Valir Rehabilitation Hospital
by Zacks Equity Research
SEM enters a definitive agreement to acquire Valir Rehabilitation Hospital and expand its inpatient rehabilitation footprint in Oklahoma City.
5 Dividend Growth Stocks to Buy in Historically Weak September
by Sweta Killa
Vertiv Holdings, Charles River, Cabot, Leidos Holdings and HCA Healthcare could be solid choices for a historically weak September.
HCA Healthcare (HCA) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.